Strategic CRM implementation elevates client service delivery across complex project lifecycles We can now easily track ...

Antengene Corporation Limited (Antengene), a leading innovative, commercial-stage global biotech company, and UCB, a global ...

UCB obtains worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, targeting B cell-related autoimmune diseasesDeal ...

FleetDomain’s Fleet Management Information System addresses the challenges and risks associated with fleet management on one ...

Inflight connectivity is evolving from a luxury to a fundamental passenger expectation, transforming the aircraft into a ...

Many private security companies have been using smartphones and apps as simple as WhatsApp to scan vehicle discs and licence ...

ESA’s Jupiter Icy Moons Explorer (JUICE) that was launched in 2023 will take about 8 years to arrive at the jovian system after several gravity assists. Credit: Space.com | animation courtesy: ESA / A ...

Belgium’s largest drugmaker UCB and Hong Kong based biotech Antengene have entered into an agreement that grants UCB a ...

Ben is the founder of Athletic Truth Group (ATG), an online and brick-and-mortar training system rooted in rehabilitative ...

Uber wants to provide all the many other ingredients of self-driving beyond the vehicle, including of course the ride hail ...

Q4 equipment units shipped for Galileo, Gogo's new cutting-edge Low Earth Orbit ("LEO") satellite broadband service, totaled 158, up 80% compared to Q3 2025. Galileo shipments in 2025 totaled 318.

Quell Therapeutics is the world leader in developing engineered T-regulatory (Treg) cell therapies that aims to harness, direct and optimize their immune suppressive properties to address serious ...